This provider's $13.5M in total Medicare payments ranks in the 93th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 39659% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 5828% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $289.01 | $94.85 | 3.05x | $194.16 | $7.7K | 81 | 3 |
| 2017 | $302.92 | $140.35 | 2.16x | $162.57 | $455.5K | 3.2K | 5 |
| 2018 | $275.17 | $140.26 | 1.96x | $134.91 | $902.1K | 6.4K | 5 |
| 2019 | $172.83 | $126.95 | 1.36x | $45.88 | $1.4M | 10.8K | 20 |
| 2020 | $106.42 | $83.09 | 1.28x | $23.33 | $2.0M | 23.9K | 59 |
| 2021 | $109.41 | $87.84 | 1.25x | $21.57 | $2.7M | 30.7K | 50 |
| 2022 | $96.65 | $78.19 | 1.24x | $18.46 | $3.1M | 39.0K | 67 |
| 2023 | $82.17 | $66.48 | 1.24x | $15.69 | $3.1M | 45.9K | 81 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 29.7K | $5.8M | $195.36 | 1.35x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 8.8K | $2.1M | $242.51 | 1.06x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 12.7K | $2.0M | $154.03 | 1.45x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 23.3K | $1.5M | $62.63 | 1.45x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 9.1K | $1.0M | $112.50 | 1.46x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.0K | $241.6K | $80.28 | 1.25x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 5.1K | $84.3K | $16.60 | 1.45x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 6.3K | $83.8K | $13.21 | 1.44x |
| 80053 | Blood test, comprehensive group of blood chemicals | 7.7K | $80.3K | $10.42 | 1.26x |
| 82306 | Vitamin d-3 level | 2.7K | $77.7K | $29.26 | 1.23x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 2.2K | $53.4K | $24.72 | 1.01x |
| 84403 | Testosterone (hormone) level, total | 2.0K | $50.6K | $25.39 | 1.46x |
| 83036 | Hemoglobin a1c level | 4.3K | $41.2K | $9.60 | 1.27x |
| 36415 | Insertion of needle into vein for collection of blood sample | 7.7K | $38.2K | $4.97 | 1.52x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 4.3K | $32.8K | $7.63 | 1.20x |
| 84153 | Psa (prostate specific antigen) measurement, total | 1.5K | $27.3K | $18.10 | 1.44x |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 3.6K | $23.3K | $6.43 | 1.40x |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 523 | $21.9K | $41.91 | 1.03x |
| 82607 | Cyanocobalamin (vitamin b-12) level | 1.3K | $19.7K | $14.94 | 1.41x |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | 503 | $19.4K | $38.55 | 1.27x |
This provider submits charges 1.34 times higher than what Medicare actually pays.
A markup ratio of 1.34x means for every $100 Medicare pays, this provider initially charges $134. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in OK for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Diagnostic Laboratory Of Oklahoma Llc | Oklahoma City, OK | $129.7M | ⚠️ Flagged |
| Saint Francis Outreach Services Llc | Tulsa, OK | $50.6M | ⚠️ Flagged |
| Dianon Systems Inc | Oklahoma City, OK | $37.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data